Lipopolysaccharide (LPS) or Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Challenge Study on Healthy Subjects
Clinical trial NCT03306589 · COMPLETED
Trial details
- NCT number
- NCT03306589
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-11
- Primary completion
- 2018-01-03
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.